Nail lesions in psoriatic arthritis: recovery with sulfasalazine treatment

• Published in: Annals of the rheumatic diseases Vol. 61; no. 3; p. 277
• Main Authors: Gerster, J C, Hohl, D
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd and European League Against Rheumatism 01.03.2002; BMJ Publishing Group Ltd; BMJ Publishing Group LTD
• Subjects: Adult; Antirheumatic Agents - therapeutic use; Arthritis, Psoriatic - complications; Arthritis, Psoriatic - drug therapy; Humans; Letter; Male; Nail Diseases - drug therapy; Nail Diseases - etiology; Patients; Psoriasis; Sulfasalazine - therapeutic use; Treatment Outcome
• ISSN: 0003-4967; 1468-2060
• DOI: 10.1136/ard.61.3.277

During the same period he started to have pain in both knee joints. Since 1998 he had also had pain in the distal interphalangeal (DIP) joints. Dermatological assessment of patients treated with sulfasalazine for PsA has been reported in two series; according to the report published in the series of Gupta et al, patients treated with sulfasalazine for PsA showed signs of cutaneous improvement compared with those receiving placebo. 1 The series of Farr et al reports improved cutaneous lesions in as few as 3/15 patients treated with sulfasalazine and 1/15 patients receiving placebo. 2 However, we could not find any indication of the evolution of possible simultaneous psoriatic nail lesions.